GNOM Stock Overview
Global X Funds - Global X Genomics & Biotechnology ETF is an exchange traded fund launched and managed by Global X Management Company LLC.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Global X Funds - Global X Genomics & Biotechnology ETF Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$9.89 |
| 52 Week High | US$13.33 |
| 52 Week Low | US$8.63 |
| Beta | 0 |
| 1 Month Change | -13.19% |
| 3 Month Change | -8.87% |
| 1 Year Change | -20.19% |
| 3 Year Change | -56.11% |
| 5 Year Change | -31.84% |
| Change since IPO | -35.67% |
Recent News & Updates
GNOM: Genomics Still Waiting For Its 'ChatGPT' Moment
Mar 22GNOM: ETF Review And Healthcare Dashboard For October
Oct 15GNOM: Poor Historical Performance, Lack Of Focus, Uncertain Future
Mar 24Global X Genomics & Biotechnology ETF: Targeted Fund Provides Strong Growth And Steady Dividend
Sep 27Recent updates
Shareholder Returns
| GNOM | US Capital Markets | US Market | |
|---|---|---|---|
| 7D | -9.1% | -2.6% | -3.7% |
| 1Y | -20.2% | 22.7% | 20.5% |
Return vs Industry: GNOM underperformed the US Capital Markets industry which returned 22.2% over the past year.
Return vs Market: GNOM underperformed the US Market which returned 20.2% over the past year.
Price Volatility
| GNOM volatility | |
|---|---|
| GNOM Average Weekly Movement | 4.3% |
| Capital Markets Industry Average Movement | 3.4% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.4% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: GNOM has not had significant price volatility in the past 3 months.
Volatility Over Time: GNOM's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2019 | n/a | n/a | www.globalxetfs.com/funds/gnom/ |
Global X Funds - Global X Genomics & Biotechnology ETF is an exchange traded fund launched and managed by Global X Management Company LLC. It invests in the public equity markets of global region. It invests in stocks of companies operating across genomic science and biotechnology, healthcare, pharmaceuticals, biotechnology and life sciences sectors.
Global X Funds - Global X Genomics & Biotechnology ETF Fundamentals Summary
| GNOM fundamental statistics | |
|---|---|
| Market cap | US$90.18m |
| Earnings (TTM) | US$0 |
| Revenue (TTM) | n/a |
n/a
P/E Ration/a
P/S RatioIs GNOM overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| GNOM income statement (TTM) | |
|---|---|
| Revenue | US$0 |
| Cost of Revenue | US$0 |
| Gross Profit | US$0 |
| Other Expenses | US$0 |
| Earnings | US$0 |
Last Reported Earnings
n/a
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did GNOM perform over the long term?
See historical performance and comparison